YESINTEK 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Biosimilar Collaborations Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 25dfa33bc83f0eec
Drug Cima Aemps Name: YESINTEK 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1241892004
Holder Company Name: Biosimilar Collaborations Ireland Limited
Marketing Company Name: Biocon Biologics Spain, S.L.
Holder Company Detail Path: /organization/biosimilar-collaborations-ireland-ltd
Authorization Date: 2025-04-09
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 130 mg/26 ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Biosimilar Collaborations Ireland Limited
Company Detail Path: /organization/biosimilar-collaborations-ireland-ltd

USTEKINUMAB

5 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 9, 2025

Approval ID

25dfa33bc83f0eec

Type

Standard